BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12400014)

  • 1. Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity.
    Yabana N; Shibuya M
    Oncogene; 2002 Oct; 21(50):7720-9. PubMed ID: 12400014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.
    Zeng L; Sachdev P; Yan L; Chan JL; Trenkle T; McClelland M; Welsh J; Wang LH
    Mol Cell Biol; 2000 Dec; 20(24):9212-24. PubMed ID: 11094073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
    Ahmed Z; Pillay TS
    Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane localization and function of Vav3 in T cells depend on its association with the adapter SLP-76.
    Charvet C; Canonigo AJ; Billadeau DD; Altman A
    J Biol Chem; 2005 Apr; 280(15):15289-99. PubMed ID: 15708849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav-family proteins in T-cell signalling.
    Tybulewicz VL
    Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mSOS-activity by binding of phosphatidylinositol 4,5-P2 to the mSOS pleckstrin homology domain.
    Jefferson AB; Klippel A; Williams LT
    Oncogene; 1998 May; 16(18):2303-10. PubMed ID: 9620547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of the pleckstrin homology and cysteine-rich domains in Vav signaling and transforming activity.
    Palmby TR; Abe K; Der CJ
    J Biol Chem; 2002 Oct; 277(42):39350-9. PubMed ID: 12177050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.
    Wollberg P; Lennartsson J; Gottfridsson E; Yoshimura A; Rönnstrand L
    Biochem J; 2003 Mar; 370(Pt 3):1033-8. PubMed ID: 12444928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
    Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
    J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3.
    Llorca O; Arias-Palomo E; Zugaza JL; Bustelo XR
    EMBO J; 2005 Apr; 24(7):1330-40. PubMed ID: 15775967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GEF at work: Vav in protruding filopodia.
    Kranewitter WJ; Danninger C; Gimona M
    Cell Motil Cytoskeleton; 2001 Jul; 49(3):154-60. PubMed ID: 11668584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and ligand recognition of the PB1 domain: a novel protein module binding to the PC motif.
    Terasawa H; Noda Y; Ito T; Hatanaka H; Ichikawa S; Ogura K; Sumimoto H; Inagaki F
    EMBO J; 2001 Aug; 20(15):3947-56. PubMed ID: 11483498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav proteins, adaptors and cell signaling.
    Bustelo XR
    Oncogene; 2001 Oct; 20(44):6372-81. PubMed ID: 11607839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes.
    Sachdev P; Zeng L; Wang LH
    J Biol Chem; 2002 May; 277(20):17638-48. PubMed ID: 11884391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
    Barnes H; Ackermann EJ; van der Geer P
    Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav3 is regulated during the cell cycle and effects cell division.
    Fujikawa K; Inoue Y; Sakai M; Koyama Y; Nishi S; Funada R; Alt FW; Swat W
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4313-8. PubMed ID: 11917103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-specific insertion near the Grb2-binding domain modulates the intrinsic guanine nucleotide exchange activity of hSos1.
    Rojas JM; Subleski M; Coque JJ; Guerrero C; Saez R; Li BQ; Lopez E; Zarich N; Aroca P; Kamata T; Santos E
    Oncogene; 1999 Mar; 18(9):1651-61. PubMed ID: 10208427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.